Probe: GLP top2a/csp17 (17q21/17p11.1-q11.1)

 

Sample: Paraffin sample (breast cancer)

 

Clinical Significance:

 

1. Determine the prognosis of breast cancer, TOP2A gene abnormalities in breast cancer patients predicts a shorter recurrence-free survival (RFS).

2. Guide clinical medication. Patients treated with TOP2A abnormalities have 65% lower risk of relapse using the CEF regimen than CM regimen, and the risk of death could be reduced by 67%; While TOP2A normal patients using CEF and CMF regimens’ curative effect is similar.

 

TOP2A Gene Amplification FISH Probe Kit

SKU: MD-BR002
Size
Item
Application
Manufacture
  • 추가문의사항은 info@imedico.co.kr 로 연락주세요.

MEDICO   

Tel : 070-8615-5557  Fax : 0504-981-5578

  • Facebook Social Icon
  • Twitter Social Icon
  • Google+ Social Icon

​Job openings   |   개인정보취급방침    |   Investment

3 대_300x.png

COPYRIGHT© 2016 by Medico. All rights reserved.